
Franklin Resources’s Intellia Therapeutics NTLA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-12,751
| Closed | -$90.7K | – | 3086 |
|
2025
Q1 | $90.7K | Sell |
12,751
-3,383
| -21% | -$24.1K | ﹤0.01% | 2807 |
|
2024
Q4 | $188K | Sell |
16,134
-271
| -2% | -$3.16K | ﹤0.01% | 2653 |
|
2024
Q3 | $320K | Buy |
16,405
+1,538
| +10% | +$30K | ﹤0.01% | 2456 |
|
2024
Q2 | $333K | Sell |
14,867
-2,377
| -14% | -$53.2K | ﹤0.01% | 2395 |
|
2024
Q1 | $474K | Buy |
17,244
+928
| +6% | +$25.5K | ﹤0.01% | 2265 |
|
2023
Q4 | $497K | Buy |
16,316
+2,372
| +17% | +$72.3K | ﹤0.01% | 1939 |
|
2023
Q3 | $441K | Sell |
13,944
-3,567
| -20% | -$113K | ﹤0.01% | 1976 |
|
2023
Q2 | $714K | Buy |
17,511
+7,642
| +77% | +$312K | ﹤0.01% | 1782 |
|
2023
Q1 | $368K | Sell |
9,869
-921
| -9% | -$34.3K | ﹤0.01% | 1793 |
|
2022
Q4 | $376K | Buy |
10,790
+298
| +3% | +$10.4K | ﹤0.01% | 1781 |
|
2022
Q3 | $588K | Sell |
10,492
-456,181
| -98% | -$25.6M | ﹤0.01% | 1644 |
|
2022
Q2 | $24.2M | Sell |
466,673
-499,965
| -52% | -$25.9M | 0.01% | 747 |
|
2022
Q1 | $70.2M | Sell |
966,638
-162,943
| -14% | -$11.8M | 0.03% | 511 |
|
2021
Q4 | $134M | Buy |
1,129,581
+150,131
| +15% | +$17.8M | 0.05% | 388 |
|
2021
Q3 | $131M | Buy |
979,450
+589,302
| +151% | +$79.1M | 0.05% | 388 |
|
2021
Q2 | $63.2M | Buy |
390,148
+376,767
| +2,816% | +$61M | 0.02% | 571 |
|
2021
Q1 | $1.07M | Buy |
13,381
+5,004
| +60% | +$401K | ﹤0.01% | 1462 |
|
2020
Q4 | $455K | Buy |
+8,377
| New | +$455K | ﹤0.01% | 1565 |
|
2017
Q2 | – | Sell |
-300,000
| Closed | -$4.23M | – | 1520 |
|
2017
Q1 | $4.23M | Hold |
300,000
| – | – | ﹤0.01% | 1131 |
|
2016
Q4 | $3.93M | Hold |
300,000
| – | – | ﹤0.01% | 1129 |
|
2016
Q3 | $5.11M | Hold |
300,000
| – | – | ﹤0.01% | 1101 |
|
2016
Q2 | $6.41M | Buy |
+300,000
| New | +$6.41M | ﹤0.01% | 1059 |
|